Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fengxu Lv"'
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 48, Iss , Pp 100967- (2024)
Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the spectrum of breast cancer. The current clinical guidelines propose treatment strategies involving cytotoxic agents like epirubicin or paclitaxel. However, the e
Externí odkaz:
https://doaj.org/article/d07873e7d0dd4d6baddbeadb51fd7d5d
Autor:
Wentao Si, Xiaodan Xu, Lijuan Wan, Fengxu Lv, Wei Wei, Xiaojun Xu, Wei Li, Dabing Huang, Leisheng Zhang, Feifei Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Breast cancer remains the most common malignancy in women and constantly threatens the lives of patients worldwide. State-of-the-art renewal has indicated the involvement of RUNX-associated transcription factor 2 (RUNX2) in tumorigenesis and cancer p
Externí odkaz:
https://doaj.org/article/44b850717cef4c988e1760d7fb69e30a